Literature DB >> 5562833

Erythrocytic nucleoside diphosphokinase. IV. Evidence for electrophoretic heterogeneity.

Y C Cheng, R P Agarwal, R E Parks.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 5562833     DOI: 10.1021/bi00787a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  6 in total

Review 1.  Quaternary structure of nucleoside diphosphate kinases.

Authors:  L Lascu; A Giartosio; S Ransac; M Erent
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

Review 2.  High-dose cytosine arabinoside: pharmacological and clinical aspects.

Authors:  W G Peters; L P Colly; R Willemze
Journal:  Blut       Date:  1988-01

3.  Microtubules and nucleoside diphosphate kinase. Nucleoside diphosphate kinase binds to co-purifying contaminants rather than to microtubule proteins.

Authors:  K Islam; R G Burns
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

Review 4.  The human Nm23/nucleoside diphosphate kinases.

Authors:  M L Lacombe; L Milon; A Munier; J G Mehus; D O Lambeth
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

5.  Molecular and structural basis of nucleoside diphosphate kinase-mediated regulation of spore and sclerotia development in the fungus Aspergillus flavus.

Authors:  Yu Wang; Sen Wang; Xinyi Nie; Kunlong Yang; Peng Xu; Xiuna Wang; Mengxin Liu; Yongshuai Yang; Zhuo Chen; Shihua Wang
Journal:  J Biol Chem       Date:  2019-06-26       Impact factor: 5.157

6.  Insight into the mechanism of inactivation of ribonucleotide reductase by gemcitabine 5'-diphosphate in the presence or absence of reductant.

Authors:  Erin Artin; Jun Wang; Gregory J S Lohman; Kenichi Yokoyama; Guixue Yu; Robert G Griffin; Galit Bar; JoAnne Stubbe
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.